- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05488275
MPFL vs Campbell in Recurrent Patella Dislocation
Prospective, Randomized, Double Blinded Trial Comparing Medial Patellofemoral Ligament Reconstruction (Hamstrings) Versus Campbell Functional Reconstruction (Non-anatomic) in Recurrent Patella Dislocation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rafał Kamiński
- Phone Number: 469 +48227794031
- Email: rkaminski@spskgruca.pl
Study Locations
-
-
Mazowieckie
-
Otwock, Mazowieckie, Poland, 05-400
- Recruiting
- Department of Orthopaedics and Traumatology, Postgraduate Center for Medical Education, Professor A. Gruca Teaching Hospital
-
Contact:
- Rafal Kaminski, MD PhD
- Phone Number: 469 +48227794031
- Email: rkaminski@spskgruca.pl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recurrent patella dislocation
- No patellofemoral joint dysplasia or Dysplasia A/B according to Dejour (non operating)
- Acceptable is to perform concomitant medialization Tibial Tubercle Osteotomy
Exclusion Criteria:
- no informed consent to participate in the study
- age under 18 years or above 65
- multiligament injury or single plane knee instability
- another musculoskeletal disorders in lower limb
- lower limb deformity requiring axis correction: valgus
- femoral anteversion (CT measurements)
- joints inflammatory diseases
- concomitant patellectomy or trochleoplasty
- ASA score > II
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: MPFL static
Medial Patellofemoral Ligament reconstruction with hamstring graft - static procedure
|
MPFL reconstruction
|
Active Comparator: Campbell
Medial Patellofemoral Ligament reconstruction using non-anatomic reconstruction (quadriceps femoris plasty - Campbell method)
|
MPFL reconstruction
|
Active Comparator: MPFL dynamic
Medial Patellofemoral Ligament reconstruction with hamstring graft - dynamic procedure
|
MPFL reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Imaging modality X-ray
Time Frame: 1 year
|
Patellofemoral Joints Biomechanics improvement measured by patella tilt
|
1 year
|
Imaging modality X-ray
Time Frame: 2 years
|
Patellofemoral Joints Biomechanics improvement measured by Q angle
|
2 years
|
Imaging modality CT
Time Frame: 2 years
|
Patellofemoral Joints Biomechanics improvement measured by Insall-Salvati ratio. The Insall-Salvati ratio or index is the ratio of the patella tendon length to the length of the patella and is used to determine patellar height. he Insall-Salvati ratio was initially determined on a 30° flexed lateral knee x-ray and was later applied to sagittal MRI. Distance lines are used to calculate Insall-Salvati ratio: A: patellar tendon length (TL): length of the posterior surface of the tendon from the lower pole of the patella to its insertion on the tibia B: patellar length (PL): greatest pole-to-pole length Insall-Salvati ratio = A/B (or TL/PL). patella baja: <0.8 normal: 0.8-1.2 patella alta: >1.2 |
2 years
|
Imaging modality CT
Time Frame: 2 years
|
Patellofemoral Joints Biomechanics improvement measured by TT-TG (line between tibial tuberosity and trochlear groove)
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional tests
Time Frame: 12 weeks
|
hop-for-distance
|
12 weeks
|
Functional tests
Time Frame: 6 months
|
hop-for-distance
|
6 months
|
Functional tests
Time Frame: 12 months
|
hop-for-distance
|
12 months
|
Functional tests
Time Frame: 24 months
|
hop-for-distance
|
24 months
|
Knee Injury and Osteoarthritis Outcome Score
Time Frame: 12 weeks,
|
Knee Injury and Osteoarthritis Outcome Score; The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability.
In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89
and the QOL subscale from 0.83-0.95.
In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92
and the QOL subscale from 0.6-0.91 (4).
|
12 weeks,
|
Knee Injury and Osteoarthritis Outcome Score
Time Frame: 6 months,
|
Knee Injury and Osteoarthritis Outcome Score;The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability.
In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89
and the QOL subscale from 0.83-0.95.
In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92
and the QOL subscale from 0.6-0.91 (4).
|
6 months,
|
Knee Injury and Osteoarthritis Outcome Score
Time Frame: 12 months
|
Knee Injury and Osteoarthritis Outcome Score; The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability.
In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89
and the QOL subscale from 0.83-0.95.
In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92
and the QOL subscale from 0.6-0.91 (4).
|
12 months
|
Knee Injury and Osteoarthritis Outcome Score
Time Frame: 24 months
|
Knee Injury and Osteoarthritis Outcome Score;The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.
KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability.
In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89
and the QOL subscale from 0.83-0.95.
In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92
and the QOL subscale from 0.6-0.91 (4).
|
24 months
|
International Knee Documentation Committee
Time Frame: 12 weeks
|
IKDC is subjective scale that provides patients with an overall function score.
Total to a scaled number ranges from 0 to 100.
higher number representing higher levels of function.
|
12 weeks
|
International Knee Documentation Committee
Time Frame: 6 months
|
IKDC is subjective scale that provides patients with an overall function score.
Total to a scaled number ranges from 0 to 100.
higher number representing higher levels of function.
|
6 months
|
International Knee Documentation Committee
Time Frame: 12 months
|
IKDC is subjective scale that provides patients with an overall function score.
Total to a scaled number ranges from 0 to 100.
higher number representing higher levels of function.
|
12 months
|
International Knee Documentation Committee
Time Frame: 24 months
|
IKDC is subjective scale that provides patients with an overall function score.
Total to a scaled number ranges from 0 to 100.
higher number representing higher levels of function.
|
24 months
|
Tegner Lysholm Knee Scoring Scale
Time Frame: 12 weeks,
|
The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support.
Scores range from 0 (worse disability) to 100 (less disability).
|
12 weeks,
|
Tegner Lysholm Knee Scoring Scale
Time Frame: 6 months,
|
The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support.
Scores range from 0 (worse disability) to 100 (less disability).
|
6 months,
|
Tegner Lysholm Knee Scoring Scale
Time Frame: 12 months
|
The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support.
Scores range from 0 (worse disability) to 100 (less disability).
|
12 months
|
Pain Visual Analog Scale
Time Frame: 12 weeks,
|
The pain VAS is a unidimensional measure of pain intensity.
The most simple VAS is a straight horizontal line of fixed length, usually 100 mm.
The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).
|
12 weeks,
|
Pain Visual Analog Scale
Time Frame: 6 months,
|
The pain VAS is a unidimensional measure of pain intensity.
The most simple VAS is a straight horizontal line of fixed length, usually 100 mm.
The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).
|
6 months,
|
Pain Visual Analog Scale.
Time Frame: 12 months,
|
The pain VAS is a unidimensional measure of pain intensity.
The most simple VAS is a straight horizontal line of fixed length, usually 100 mm.
The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).
|
12 months,
|
Pain Visual Analog Scale
Time Frame: 24 months
|
The pain VAS is a unidimensional measure of pain intensity.
The most simple VAS is a straight horizontal line of fixed length, usually 100 mm.
The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).
|
24 months
|
Knee Injury and Osteoarthritis Outcome Score Patellofemoral
Time Frame: 12 weeks
|
the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA.
This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability
|
12 weeks
|
Knee Injury and Osteoarthritis Outcome Score Patellofemoral
Time Frame: 6 months,
|
the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA.
This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability
|
6 months,
|
Knee Injury and Osteoarthritis Outcome Score Patellofemoral
Time Frame: 12 months
|
the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA.
This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability
|
12 months
|
Knee Injury and Osteoarthritis Outcome Score Patellofemoral
Time Frame: 24 months
|
the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA.
This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability
|
24 months
|
The Victorian Institute of Sport Assessment
Time Frame: 12 weeks,
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
minimum 0, maximum 100 for asymptomatic
|
12 weeks,
|
The Victorian Institute of Sport Assessment
Time Frame: 6 months,
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
minimum 0, maximum 100 for asymptomatic
|
6 months,
|
The Victorian Institute of Sport Assessment
Time Frame: 12 months,
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
minimum 0, maximum 100 for asymptomatic
|
12 months,
|
The Victorian Institute of Sport Assessment
Time Frame: 24 months
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
minimum 0, maximum 100 for asymptomatic
|
24 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rafał Kamiński, PCME, Otwock, Poland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mpfl_campbell
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recurrent Patella Dislocation
-
City, University of LondonOxford University Hospitals NHS TrustCompletedPatella Dislocation | Patella Dislocation RecurrentUnited Kingdom
-
Polish Mother Memorial Hospital Research InstituteCompletedChildren, Only | Patella Dislocation Recurrent
-
Meir Medical CenterCompletedPatella-DislocationIsrael
-
Finnish Defense ForcesTampere University HospitalTerminatedPatellofemoral Osteoarthritis | Patellar Instability | Patella-DislocationFinland
-
University Hospital, Basel, SwitzerlandUniversity Children's Hospital Basel; Lab. for Orthopaedic Biomechanics, University...CompletedPatella-DislocationSwitzerland
-
Children's Hospital Medical Center, CincinnatiCompletedPatellar Dislocation | Patella Dislocation RecurrentUnited States
-
Meir Medical CenterRambam Health Care Campus; Hadassah Medical Organization; Assaf-Harofeh Medical... and other collaboratorsUnknownPatella, Familial Recurrent Dislocation OfIsrael
-
Orthopedic Specialty InstituteTerminatedDislocated Patella | Torn Medial Patellofemoral LigamentUnited States
-
Columbia UniversityNot yet recruiting
-
Medical University of GrazCompleted
Clinical Trials on Surgery
-
University of AarhusCompletedAcute Post Operative Pain | Chronic Postsurgical PainDenmark
-
International Study Group on Minimally Invasive...Fondazione CARIT; LOGIX S.r.l.Unknown
-
Peking Union Medical College HospitalCompletedPancreatic Neuroendocrine TumorsChina
-
Hospital Central de la Defensa Gómez UllaClinica Universidad de Navarra, Universidad de NavarraEnrolling by invitationRectal Cancer | PROM | Functional Bowel DisorderSpain
-
Sunnybrook Health Sciences CentreMcMaster University; Unity Health Toronto; University of Toronto; University of... and other collaboratorsCompleted
-
The Second Hospital of Shandong UniversityRecruitingLung Diseases | SurgeryChina
-
Federal University of São PauloUnknownObesity | LymphedemaBrazil
-
Shanghai Zhongshan HospitalUnknownCarcinoma, Pancreatic Ductal | Circulating Tumor CellsChina
-
NHS GrampianBarts & The London NHS Trust; Queen Mary University of London; University of...RecruitingOvarian CancerUnited Kingdom
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruitingQuality of Life | Lung NeoplasmsUnited Kingdom